What is the current Price Target for the Viking Therapeutics, Inc. stock?

The average Viking Therapeutics, Inc. target price is $102.00. This is 251.85% higher than the current stock price. The highest price target is 352.74%, the lowest is 21.94%. 20 Analysts have issued a price target Viking Therapeutics, Inc. 2027 .

How high will the Viking Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Viking Therapeutics, Inc. stock will rise. The performance of stocks, including the Viking Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Viking Therapeutics, Inc. stock today?

The performance of Viking Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Viking Therapeutics, Inc. stock fall?

The decline in Viking Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Viking Therapeutics, Inc. Forecast, price target & analysts

$28.99

1.26%

Nasdaq, Sep 18, 04:21 pm EDT. Closed.

ISIN

US92686J1060

Symbol

VKTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Viking Therapeutics, Inc. Target price 2026 - Analyst rating & recommendation

Viking Therapeutics, Inc. Classifications & Recommendation

Buy

88%

Hold

12%

Viking Therapeutics, Inc. Price Target

Target Price	$102.00
Price	$28.99
Potential	251.85% register free of charge
Number of Estimates	20

	20 Analysts have issued a price target Viking Therapeutics, Inc. 2027 . The average Viking Therapeutics, Inc. target price is $102.00. This is 251.85% register free of charge higher than the current stock price. The highest price target is $131.25 352.74% register free of charge , the lowest is $35.35 21.94% register free of charge .
	A rating was issued by 26 analysts: 23 Analysts recommend Viking Therapeutics, Inc. to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Viking Therapeutics, Inc. stock has an average upside potential 2027 of 251.85% register free of charge . Most analysts recommend the Viking Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-3.19	-4.54
	215.84%	42.32%
P/E		negative

22 Analysts have issued a Viking Therapeutics, Inc. forecast for earnings per share. The average Viking Therapeutics, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-3.19	215.84%
2026	$-4.54 42.32% unlock
2027	$-4.50 0.88% unlock
2028	$-3.86 14.22% unlock
2029	$-1.51 60.88% unlock
2030	$2.89 291.39% unlock
2031	$9.46 227.34% unlock
2032	$17.34 83.30% unlock
2033	$27.35 57.73% unlock

Current	-6.32	61.05%
2026	-6.38 1.01% unlock
2027	-6.44 0.94% unlock
2028	-7.52 16.77% unlock
2029	-19.26 156.12% unlock
2030	10.03 152.08% unlock
2031	3.06 69.49% unlock
2032	1.67 45.42% unlock
2033	1.06 36.53% unlock

Viking Therapeutics, Inc....

Current Viking Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Aug 11 2026
Canaccord Genuity	Locked ➜ Locked	Locked	Jul 30 2026
Lake Street	Locked ➜ Locked	Locked	May 28 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Apr 30 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 23 2026
Canaccord Genuity	Locked ➜ Locked	Locked	Nov 12 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Oct 29 2025

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Aug 11 2026
Locked Canaccord Genuity: Locked ➜ Locked	Jul 30 2026
Locked Lake Street: Locked ➜ Locked	May 28 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Apr 30 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 23 2026
Locked Canaccord Genuity: Locked ➜ Locked	Nov 12 2025
Locked Canaccord Genuity: Locked ➜ Locked	Oct 29 2025

Discover more stocks with a high price target

NIO ADR 100.10%

Alibaba Group Holding Ltd 68.75%

Infineon 65.25%

Tencent Holdings Ltd. 63.10%

Rheinmetall 61.30%

TUI 56.70%

Adyen 53.16%

Siemens Energy 49.14%

Adidas 46.64%

Uber Technologies 46.13%

BYD 40.95%

NVIDIA 37.67%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now